Minoxidil

Overview

Minoxidil began as a blood pressure medication. The hair growth observed as a side effect in patients led to the topical product, which is now one of only two treatments approved for androgenetic alopecia.

For anyone using anabolic compounds, it holds a specific position: it works through a mechanism that has nothing to do with DHT. That makes it the option that still applies where finasteride does not.

Mechanism of Action

Minoxidil opens potassium channels and dilates blood vessels, improving perfusion around the follicle. Beyond that it appears to prolong the growth phase of the hair cycle and shorten the resting phase, and it influences growth factors in the follicle directly. The full mechanism is not completely resolved.

What matters practically is what it does not involve: androgen receptors, DHT, or the conversion between them. Minoxidil does not reduce the androgenic pressure on the follicle — it acts on the follicle's growth behaviour despite that pressure.

This is why it is the answer to a question finasteride cannot address. Under drostanolone, stanozolol or oxandrolone, the follicle is under attack from a DHT derivative that no 5-alpha-reductase inhibitor can touch. Minoxidil does not care about the source of the androgen; it works on the growth cycle regardless.

It is a prodrug — the follicle must activate it via sulfotransferase, and the activity of that enzyme varies between people. This explains topical non-responders, and it is part of why the oral form has gained ground.

Typical Context

Topically, one millilitre of five percent solution or foam twice daily, indefinitely. Results take three to six months.

The single most important thing to know before starting: shedding increases in the first two to eight weeks. This is expected. Follicles are being pushed out of their resting phase into a new growth cycle, and the old hair falls out to make room for the new one. It looks like the treatment is accelerating the problem, and it is the point at which most people quit — immediately before the phase where it starts working.

Low-dose oral minoxidil has become considerably more common, at a fraction of the blood pressure dose. It bypasses the absorption and sulfotransferase problems and is more convenient than twice-daily application. The trade-off is that it is systemic: fluid retention, elevated heart rate and body hair growth are all dose-dependent and all real. For anyone already running compounds that raise blood pressure, adding an antihypertensive with fluid retention as a side effect is a combination that belongs with a doctor.

Side Effects & Risks

• Initial shedding in the first weeks
• Scalp irritation, flaking, itching — mostly from propylene glycol in solutions
• Oral form: fluid retention, swollen ankles, elevated heart rate
• Oral form: body and facial hair growth (hypertrichosis)
• Oral form: blood pressure effects
• Unwanted hair growth on the face from topical runoff
• Effect ends completely on discontinuation

Blood Work & Monitoring

• Blood pressure and resting heart rate — for the oral form, measured at home
• Kidney values (creatinine, eGFR) — relevant with oral use
• Electrolytes — fluid retention can shift them

Harm-Reduction Notes

• The initial shedding is expected — stopping then means quitting right before it works
• It works independently of DHT, which is why it applies under DHT-derived compounds where finasteride does not
• Foam rather than solution if irritation occurs; the solvent is usually the cause
• Oral minoxidil is a blood pressure drug — combined with compounds that already raise it, this belongs under medical supervision
• Apply to a dry scalp and let it dry before lying down, to limit facial runoff
• It is an indefinite commitment; stopping returns you to baseline within months